Profiling Inflammatory Biomarkers following Curcumin Supplementation: An Umbrella Meta-Analysis of Randomized Clinical Trials

Table 1

Study characteristics of included studies.

Citation (first author et al., year)	No. of studies in meta-analysis	Country	No. of participants in meta-analysis	Mean age (years)	Duration of intervention	Dose (mg/daily)	Quality assessment scale and outcome
Ebrahimzadeh et al. 2021 [24]	6	Iran	167	609	10.5 weeks	583	Yes (Cochrane) 3/6 high
Ashtary-Larky et al. 2021 [25]	5	Iran	298	51	10 weeks	100	Yes (Cochrane) 4/5 high
Gorabi et al. 2021 [26]	17	Iran	1033	49	8 weeks	900	Yes (Jadad score) NR
Sahebkar et al. 2014 [27]	6	Iran	342	48	4.5 weeks	1900	Yes (Cochrane) 4/6 high
Sahebkar et al. 2016 [28]	8	Iran	449	52	7 weeks	1014	Yes (Cochrane) 2/8 high
Tabrizi et al. 2018 [29]	11	Iran	797	NR	7 weeks	950	Yes (Cochrane) 10/11 high
Abdelazeem et al. 2021[30]	2	USA	81	29	7 weeks	300	Yes (Cochrane) 1/2 high
White et al. 2019 [31]	8	USA	654	46	8 weeks	686	Yes (Cochrane) 2/8 high
Ferguson et al. 2020 [32]	19	Australia	1440	49	8 weeks	512	Yes (Cochrane) 7/19 high
Derosa et al. 2016 [33]	9	Italy	609	51.5	9 weeks	1422	Yes (Cochrane) 3/9 high

NR, not reported.